About: Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.93 (-10.83%)
ADILNASDAQAdial Pharmaceuticals Inc
Adial Pharmaceuticals Inc share price
ADIL price activity
Last Price
$5.930
Change (24hr)
-0.72 USD (-10.83%)
Volume
48.27K
Volume (4w avg)
-
Open
$6.64
Day Range
$5.87 - $6.65
Previous Close
$6.65
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
ADIL price performance
Delayed
09 Sep, 8:00 pm GMT+0
ADIL Market Signals